Related Experiment Video

Updated: Aug 29, 2025

A Semi-Quantitative Drug Affinity Responsive Target Stability DARTS assay for studying Rapamycin/mTOR interaction
05:28

A Semi-Quantitative Drug Affinity Responsive Target Stability DARTS assay for studying Rapamycin/mTOR interaction

Published on: August 27, 2019

16.6K

A Perspective Study on the RTK, PI3K, B-Raf, CDK and the Multi-Protein Targeting in Medicinal Chemistry

Abdalla R Mohamed1, Ahmed M El Kerdawy2

  • 1Pharmaceutical Chemistry Department, Faculty of Pharmacy, Egyptian Russian University, Badr City, Cairo 11829, Egypt.

Chemistry & Biodiversity
|September 6, 2022
PubMed

Insights

Targeting cell maturation pathways like RTK, PI3K, B-Raf, and CDK is key for cancer drugs. Understanding resistance mechanisms and multi-kinase inhibition is crucial for developing effective antitumor agents.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Cellular signaling pathways (RTK, PI3K, B-Raf, CDK) are vital for cell maturation and are critical antitumor drug targets.
  • Isoform diversity in these pathways enables cancer cells to develop resistance to targeted therapies.
  • Cancer's complexity necessitates understanding molecular resistance mechanisms to targeted signaling pathways.

Purpose of the Study:

  • To illustrate the complex nature of cancer.
  • To present molecular tracing of tumor resistance to specific signaling pathways.
  • To highlight interventions for antitumor agent development and discuss targeted multi-kinase inhibition strategies.

Main Methods:

  • Literature review of cancer signaling pathways.
  • Analysis of molecular mechanisms of drug resistance.
  • Survey of targeted multi-kinase inhibition approaches.
  • Discussion of structural basis for protein kinase inhibitor design.

Main Results:

  • Identified key cellular signaling pathway components as crucial antitumor drug targets.
  • Elucidated diverse resistance mechanisms employed by cancer cells due to pathway isoform diversity.
  • Presented interventions for developing novel antitumor agents.
  • Discussed antitumor activities of kinase-targeting chemotherapies and protein kinase inhibitor design.
  • Included a literature survey on multi-kinase inhibition to overcome resistance.

Conclusions:

  • Targeting key signaling pathways offers a promising avenue for cancer therapy.
  • Understanding and overcoming drug resistance through strategies like multi-kinase inhibition is essential.
  • Further research into structural biology and targeted therapies can lead to more effective antitumor agents.
Keywords:
B-RafPI3KRTKanticancermulti-kinase targeting

More Related Videos

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays07:42

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays

Published on: September 19, 2018

8.0K
Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays13:22

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays

Published on: October 23, 2019

8.0K

Related Concept Videos

Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
2.7K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
7.2K
Protein-protein Interfaces02:04

Protein-protein Interfaces

Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.7K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K